Doctors take care of patients. We take care of families. To learn more or to make a gift, visit rmhccnaz.org Central & Northern Arizona Empowering leaders to diversify revenue, develop teams and thrive. Experience — Becky has served at the executive level in the three major sectors: corporate, association management and nonprofit. Leadership — Becky has revitalized struggling organizations with her deep expertise in succession planning, team development and capital campaigns. Wisdom — After being a bank president and the CEO of four nonprofits and a chamber of commerce, Becky knows what works, what doesn’t and how to tell the difference. Schedule a free 30-minute assessment to learn how Becky can help you or your organization. Go to: becky-jackson .com Helping nonprofits to build, change and sustain.

O ne year ago, I wrote a column about the work that the Translational Genomics Research Institute (TGen) was doing to combat the COVID-19 pandemic. Everything was big and scary at the time. But here we are today, with hopefully some light at the end of the tunnel. So, I thought it would be a good time to check back in with TGen and see how the pandemic has unfolded from their perspective — but also how they’ve been able to continue to focus on other diseases and research as well. The first person I talked with was Dr. David Engelthaler, an associate professor at Northern Arizona University and the co-director of TGen’s Pathogen and Microbiome Division. I couldn’t help but think that for TGen leads Arizona’s COVID-19 response while pressing forward with research Dr. David Engelthaler, co-director of TGen’s Pathogen and Microbiome Division Tom Evans | Contributing Editor “WE HAVE THE ABILITY; THEREFORE WE HAVE THE RESPONSIBILITY” FRONTDOORS MEDIA | 39 | MAY/JUNE 2021 NEXT DOORS {ahead of the curve}